A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ajit Puri, MD
University of Massachusetts, Worcester
Principal Investigator - Guilherme Dabus, MD
Baptist Health - Miami
Principal Investigator - Thanh Nguyen, MD
Boston Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Auckland City Hospital
Auckland, New Zealand
- Banner Health
Mesa, Arizona, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Christiana Care
Newark, Delaware, United States
- Baptist Jacksonville
Jacksonville, Florida, United States
- Baptist Hospital of Miami
Miami, Florida, United States
- Advocate Aurora Health
Chicago, Illinois, United States
- University of Kansas
Kansas City, Kansas, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Tufts
Boston, Massachusetts, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- Saint Luke'S
Kansas City, Missouri, United States
- Cooper Health System
Camden, New Jersey, United States
- Rutgers
Piscataway, New Jersey, United States
- Stony Brook University Hospital
Stony Brook, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio Health
Columbus, Ohio, United States
- Wright State University
Dayton, Ohio, United States
- Mercy Health St. Vincent
Toledo, Ohio, United States
- Ohsu
Portland, Oregon, United States
- Geisinger Clinic
Danville, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Upmc
Pittsburgh, Pennsylvania, United States
- Fort Sanders Medical Center
Knoxville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Valley Baptist
Harlingen, Texas, United States
- Medical City Plano
Plano, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- West Virginia University
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2021
- Primary completion
- 19 Feb 2024
- Completion
- 22 May 2024
- Last update posted
- 9 Apr 2025
- Registered enrollment
- 250
- Registry id
- NCT05018650
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.